An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)

Roche

Status: Completed

Conditions: Colorectal Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT01555762

ML27829

Details and patient eligibility

About

This multicenter, prospective, observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in first-line therapy in elderly patients with metastatic colorectal cancer. Data will be collected from eligible patients for24 months.

Enrollment: 402 patients

Sex: All

Ages: 75+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients, >/= 75 years of age
• Metastatic colorectal cancer
• Initiating Avastin first-line therapy in combination with chemotherapy

Exclusion criteria

• Previous Avastin therapy
• Patient participating in a clinical study evaluating a cytotoxic anti-cancer therapy and/or an investigational new drug

Trial design

402 participants in 1 patient group

Cohort